Impact China Event in Shanghai to Highlight Burgeoning R&D Outsourcing and Partnership Opportunities for Multinational Pharma, Biotech and CRO Companies: "IMPACT CHINA III: Pharmaceutical R&D Global Summit
NEW YORK--(BUSINESS WIRE)--Pharmaceutical and biotech companies from the West and Asia will convene in Shanghai this May 20-23 at “IMPACT CHINA III: Pharmaceutical R&D Global Summit” to discuss the current trends and challenges facing China’s fast-growing pharmaceutical sector. China has quickly become the international destination of choice for the multinational pharmaceutical and biotech companies who are looking to China to help strengthen and expedite their drug discovery and development efforts.
"
